focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE
Stephen Yiu, FM at WS Blue Whale, discusses Nvidia, Visa/Mastercard, Lam Research & Allied Materials
Stephen Yiu, FM at WS Blue Whale, discusses Nvidia, Visa/Mastercard, Lam Research & Allied MaterialsView Video
Ben Turney, CEO at Kavango Resources, explains the company's progress from exploration to mining
Ben Turney, CEO at Kavango Resources, explains the company's progress from exploration to miningView Video

Latest Share Chat

Full Year Trading Update

20 Jan 2023 07:00

RNS Number : 3312N
Devro PLC
20 January 2023
 

Devro plc

 

Full Year Trading Update

 

Devro plc ("Devro" or the "Group"), one of the world's leading manufacturers of collagen products for the food industry, issues the following trading update for the period 1 January to 31 December 2022 ("period").

Current trading

The Group traded well throughout the period with reported revenue of circa £290m reflecting growth of around 15% (11% at constant currency) compared to 2021. Constant currency revenue growth was driven by higher pricing, reflecting successful recovery of cost inflation, as well as good volume increases particularly in our mature markets.

The second half of the year delivered strong operating margins, reflecting the benefits of management's pricing actions, operating efficiency and foreign exchange tailwinds. 

As a result, adjusted operating profit is anticipated to be ahead of the Board's expectations, subject to any audit adjustments.

Financial position

Cash generation in the period remained robust, despite higher working capital and capital expenditure to facilitate further growth, with Group covenant net debt of around £90m at year end.

ENDS

Contacts:

Devro plc

Chris Dyett

Tel : 07974 974 690

Investor Relations

 

FTI Consulting

Richard Mountain

Tel: 07909 684 466

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTSFSESUEDSEFF

Related Shares

Back to RNS

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.